Document is current
Any future updates will be listed below
-
Authors
Xu, Yinggang
Huang, Lifeng
Wang, Jue
He, Jinzhi
Wang, Ye
Zhang, Weiwei
Chen, Rui
Huang, Xiaofeng
Liu, Jin
Wan, Xinyu
Shi, Wenjie
Xu, Lu
Zha, Xiaoming
-
Funding
Funding for this research was provided by:
Chinese Society of Clinical Oncology (Y-sy2018-077)
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 6 November 2024
First Online: 12 November 2024
Declarations
:
: This study was approved by the First Affiliated Hospital of Nanjing Medical University’s Ethics and Research Committee (2021-SR-072), and the study was carried out in compliance with the Helsinki Declaration’s guidelines and the institutional and national accountable committees on human experimentation. Each patient’s informed consent was acquired (every patient signed an informed consent form before receiving treatment).
: Not applicable.
: The authors declare no competing interests.
